Browsing by Author Olgun, N.

Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
2016Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?Demir, B.; Aktas, S.; Altun, Z.; Ercetin, P.; Olgun, N.
2018Could Manganese-Superoxide Dismutase be a Biomarker in Neuroblastoma?Altun, Z.; Aktas, S.; Demir, B.; Serinan, E.; Aktas, T.; Olgun, N.
2021Questioning How to Define the Ultra-High-Risk Subgroup of Neuroblastoma PatientsDemir, A. B.; Aktas, S.; Altun, Z.; Ercetin, P.; Aktas, T. C.; Olgun, N.